Insiders · SCPH

SCPH insider transactions

scPharmaceuticals Inc. (SCPH) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for SCPH

• 243d
  Director Schaeffer Leonard D closing all direct ownership in the company (SEC Form 4)

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 243d
  CFO and Treasurer Nokes Rachael returned 125,675 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 243d
  SEC Form 4 filed by Director Baylor-Henry Minnie

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 243d
  SEC Form 4 filed by Director Hudson Frederick M.

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 243d
  President and CEO Tucker John H returned 318,502 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 243d
  SEC Form 4 filed by Director Veitinger Klaus R Dr

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 243d
  SEC Form 4 filed by Director Abraham William Tober

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 243d
  SEC Form 4 filed by Director Bonstein Sara

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 243d
  SEC Form 4 filed by Director Agger Mette Kirstine

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 243d
  Director Khattar Jack A. closing all direct ownership in the company (SEC Form 4)

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 367d
  SEC Form 4 filed by Director Agger Mette Kirstine

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 367d
  SEC Form 4 filed by Director Baylor-Henry Minnie

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 367d
  SEC Form 4 filed by Director Bonstein Sara

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 367d
  SEC Form 4 filed by Director Hudson Frederick M.

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 367d
  SEC Form 4 filed by Director Khattar Jack A.

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 367d
  SEC Form 4 filed by Director Veitinger Klaus R Dr

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 367d
  SEC Form 4 filed by Director Abraham William Tober

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 367d
  SEC Form 4 filed by Director Schaeffer Leonard D

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 480d
  President and CEO Tucker John H gave a grant of 200,000 shares, decreasing direct ownership by 31% to 440,847 units (SEC Form 4)

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 480d
  CFO and Treasurer Nokes Rachael was granted 88,445 shares, increasing direct ownership by 131% to 156,061 units (SEC Form 4)

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 516d
  CFO and Treasurer Nokes Rachael covered exercise/tax liability with 5,235 shares, decreasing direct ownership by 7% to 67,616 units (SEC Form 4)

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 516d
  President and CEO Tucker John H covered exercise/tax liability with 13,360 shares, decreasing direct ownership by 5% to 240,847 units (SEC Form 4)

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 648d
  Amendment: CFO and Treasurer Nokes Rachael exercised 10,445 shares at a strike of $1.66, increasing direct ownership by 17% to 72,851 units (SEC Form 4)

  4/A - scPharmaceuticals Inc. (0001604950) (Issuer)
• 648d
  Director Schaeffer Leonard D exercised 11,347 shares at a strike of $2.58, increasing direct ownership by 26% to 54,451 units (SEC Form 4)

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 661d
  Large owner Orbimed Advisors Llc bought $2,000,000 worth of shares (500,000 units at $4.00) (SEC Form 4)

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 668d
  CFO and Treasurer Nokes Rachael converted options into 10,445 shares, increasing direct ownership by 17% to 72,851 units (SEC Form 4)

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 724d
  SEC Form 4 filed by Director Hudson Frederick M.

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 724d
  SEC Form 4 filed by Director Abraham William Tober

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 724d
  SEC Form 4 filed by Director Schaeffer Leonard D

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 724d
  SEC Form 4 filed by Director Baylor-Henry Minnie

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 724d
  SEC Form 4 filed by Director Veitinger Klaus R Dr

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 724d
  SEC Form 4 filed by Director Khattar Jack A.

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 724d
  SEC Form 4 filed by Director Bonstein Sara

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 724d
  SEC Form 4 filed by Director Agger Mette Kirstine

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 796d
  SEC Form 4 filed by Tucker John H

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 867d
  Nokes Rachael was granted 41,840 shares, increasing direct ownership by 203% to 62,406 units (SEC Form 4)

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 867d
  Tucker John H was granted 113,560 shares, increasing direct ownership by 81% to 254,207 units (SEC Form 4)

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 886d
  Nokes Rachael covered exercise/tax liability with 1,027 shares, decreasing direct ownership by 5% to 20,566 units (SEC Form 4)

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 886d
  Tucker John H covered exercise/tax liability with 4,942 shares, decreasing direct ownership by 3% to 140,647 units (SEC Form 4)

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 1095d
  SEC Form 4 filed by Agger Mette Kirstine

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 1095d
  SEC Form 4 filed by Baylor-Henry Minnie

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 1095d
  SEC Form 4 filed by Veitinger Klaus R Dr

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 1095d
  SEC Form 4 filed by Abraham William Tober

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 1095d
  SEC Form 4 filed by Bonstein Sara

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 1095d
  SEC Form 4 filed by Hudson Frederick M.

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 1095d
  SEC Form 4 filed by Khattar Jack A.

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 1095d
  SEC Form 4 filed by Schaeffer Leonard D

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 1231d
  SEC Form 4: Tucker John H was granted 66,665 shares, increasing direct ownership by 84% to 145,589 units

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 1231d
  SEC Form 4: Nokes Rachael covered exercise/tax liability with 3,957 shares and was granted 11,700 shares, increasing direct ownership by 56% to 21,593 units to cover withholding tax

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 1266d
  SEC Form 4 filed by Nokes Rachael

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 1286d
  SEC Form 4: Orbimed Advisors Llc bought $4,002,495 worth of shares (762,380 units at $5.25)

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 1335d
  SEC Form 4: 5am Partners Iv, Llc sold $2,488,907 worth of shares (600,000 units at $4.15)

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 1335d
  SEC Form 4: Tucker John H converted options into 42,250 shares and covered exercise/tax liability with 10,288 shares, increasing direct ownership by 68% to 78,924 units to satisfy tax liability

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 1368d
  SEC Form 4: 5am Partners Iv, Llc sold $1,096,953 worth of shares (226,622 units at $4.84)

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 1453d
  SEC Form 4 filed by Abraham William Tober

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 1453d
  SEC Form 4 filed by Veitinger Klaus R Dr

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 1453d
  SEC Form 4 filed by Bonstein Sara

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 1453d
  SEC Form 4 filed by Hudson Frederick M.

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 1453d
  SEC Form 4 filed by Baylor-Henry Minnie

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)
• 1453d
  SEC Form 4 filed by Schaeffer Leonard D

  4 - scPharmaceuticals Inc. (0001604950) (Issuer)